Skip to main content
. 2022 Sep 6;156:105292. doi: 10.1016/j.jcv.2022.105292

Table 2.

Comparison of test measurements produced by Abbott RBD, DiaSorin Trimeric S, Roche Elecsys and GenScript cPass assays in EDTA plasma, heparin plasma and serum samples.

Abbott RBD DiaSorin TrimericS Roche Elecsys GenScript cPass P-value
EDTA Plasma, n = 60
Positive, n 30 31 34 25
Titer, BAU/mL 0.30
Min 17.2 39 0.9 36.1
Median, IQR 130.4 (47.2, 431.9) 291 (140, 1190) 138.6 (38.3, 1764.4) 259.2 (77, 453.6)
Max 2405.9 33,100 54,001.7 21,021.3
Heparin Plasma, n = 60
Positive, n 32 29 32 24
Titer, BAU/mL 0.10
Min 7.4 46 3.0 37.0
Median, IQR 114.8 (27.3, 561.7) 419 (145, 1120) 97.6 (34, 640.5) 150.1 (69.6, 433.4)
Max 2467.7 7060 10,293.1 2913.8
Serum, n = 60
Positive, n 30 30 33 30
Titer, BAU/mL <0.0001
Min 231.6 614 2.5 320.3
Median, IQR 923 (465.8, 1670) 1750 (1170, 3000) 5917.7 (3010.3, 8154.3) 1279 (806.3, 2267.5)
Max 6056.0 8770 33,954.5 9616.9

P-values generated from comparing medians using the Kruskal-Wallis test, significant at < 0.05.

Min: minimum.

Max: maximum.